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Vascular injury is identified during pre-clinical toxicity testing within certain 
pharmacological classes of drug candidates and induces degenerative and hyperplastic 
changes in endothelial (ECs) and vascular smooth muscle (VSMCs) cells. This drug-
induced vascular injury has been shown as a side-effect caused by various classes of drugs, 
including, antibacterial (e.g., azithromycin), antimalarial (e.g., quinoline), anti-viral (e.g., 
anti-hepatitis C virus interferons) and nonsteroidal anti-inflammatory drugs (e.g., 
ibuprofen), and affects normal cardiovascular function and can further lead to various 
cardiovascular conditions like arrhythmia, cardiac arrest, high blood pressure, and even 
heart attack. The search for agents capable of reducing vascular injury side-effects by drugs 
is a very active and important pharmacological field. Dietary polyphenols have been shown 
to protect the vasculature against drug-induced vascular injury by directly affecting both, 
VSMCs and ECs. We propose polyphenols like pentagalloyl glucose (PGG), punicalagin, 
and quercetin can be an excellent choice as a vascular protectant against the injury caused 




Our study focuses on the a) development of an ex vivo rat aortic model under a peristaltic 
flow, and b) testing the vascular protective effects of different polyphenols when our model 
system is exposed to drugs affecting the vasculature. We will focus on three polyphenols 
(i.e., PGG, punicalagin, and quercetin) and two drugs (i.e., acetylcholine and 
phenylephrine). With acetylcholine, known to induce EC-dependent vasodilation, and 
phenylephrine, known to induced contraction of VSMCs. The result will show the damage 
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         Cardiovascular diseases (CVD) are one of the major causes of non-communicable 
illness in the world, with 17.5 Million people dying each year from them, representing 
31% of the global deaths1. Most of the CVD initiate with vascular damage, which can 
result in coronary heart diseases (CHD), atherosclerosis, and even heart attacks. There 
have been various studies which show how different drugs like anti-bacterial, anti-viral, 
and non-steroidal inflammatory agents lead to vascular injury. When it comes to 
preclinical studies for any drug candidates, drug-induced vascular injury effects the 
prescreening of a drug candidate as there are no established biomarkers to monitor it2.  
 
1.2 ANATOMY 
The aorta is the largest artery of the body, which starts from the left ventricle of the 
heart (Figure 1). The aorta is one of the most widely studied blood vessels, with studies 
spanning many years of research. The aortic root is a part of the aorta that is attached 
directly to heart, which further connects to the ascending aorta, following through the 
aortic arch and connecting to the descending aorta, which is divided into the thoracic 
and abdominal sections. Cardiovascular studies have mainly focused on rat aorta as a 
model system, with many of them studying the functionality and mechanistic effects of 
various conditions or treatments on this vessel. Proof of this is shown by the fact that 
about 4503 articles were published with a keyword “Rat Aorta” from 1955-2013 as 
indexed in Medline3. 






                                        














Figure 1: Structure of the aorta. Adapted from; Image source <https://www.cedarssinai.edu/Patients/ 
Health-Conditions/Aortic-Aneurysm.aspx> 
 
1.3 ROLE OF ENDOTHELIAL DYSFUNCTION IN CVD 
 
It is known that endothelial dysfunction plays an important role in the progression of CVD. In the 
case of atherogenesis, endothelial dysfunction is characterized by a decrease in the production of 
nitric oxide (NO), which is a vasodilator affecting vascular smooth muscle cells (VSMCs)4. The 
main cause is due to exposure to reactive oxygen species (ROS). Thus, maintaining the balance 
between ROS and NO plays an important role in the prevention of endothelial dysfunction. Also, 
NO plays a critical role in maintaining vascular integrity, being a vasodilator, it opposes certain 
vasoconstrictors like endothelin-15. NO is synthesized by endothelial nitric oxide synthase 
(eNOS), which is present on endothelial cells. L-arginine and oxygen are used as a substrate by 
eNOS to produce NO and l-citrulline, through the transfer of electrons by NADPH from the 
reductase domain to the oxidase domain5. Tetra-hydrobiotropein (BH4) is an essential co-factor, 




(GTPCH). eNOS can be either coupled (i.e., dimeric form) or uncoupled (i.e., monomeric form), 
controlling the balance between NO and ROS production. Presence of BH4 allows coupling of 
eNOS and the production of NO. BH4 is sensitive to degradation by ROS, which leads to 
disturbance in electron flow in eNOS, which further makes eNOS to produce superoxide instead 
of NO. It also leads to inhibition of endothelium-dependent vasodilation and results in endothelial 
dysfunction6.   
There are various drugs like phenylephrine (PE), which induce contraction of VSMCs by rising 
[Ca2+]i concentration, which induces a rise in EC [Ca
2+]i concentration, and result in the release of 
NO. Another drug would be acetylcholine (ACh), which induces a rise in EC [Ca2+]i concentration, 
and the release of NO, which diffuses to neighboring SMCs and relaxes them. ECs can also 
synthesize Flow-induced ACh for autocrine stimulation, which is why these cells are so sensitive 
to this molecule.   
1.4 ROLE OF COLLAGEN AND ELASTIN IN STRUCTURAL INTEGRITY 
Collagen and elastin play an essential role in the structural integrity of aorta. Collagen constitutes 
one-fourth of the protein in most of the animals7. In the aorta, there are two main types of collagen 
which constitute 80- 90 % of the total content of collagen, which is Type I and Types III8. Other 
types like Type IV and Type V are situated very near to endothelial and smooth muscle cells, along 
with Type I and Type III8. Collagen plays an important role in vessel wall repair and regeneration9. 
Various polyphenols like punicalagin have shown its ability to inhibit the degradation of collagen. 
Elastin is another essential protein in the extracellular matrix, which plays an important role in 
providing structural integrity and elasticity to the aorta10. It also plays a role in cell behavior, which 
leads and helps in the modulation of the cascade11.  
1.5 CURRENT GOLD STANDARD TREATMENT FOR CVD 
 
In CVD’s statins are considered as a gold standard of treatment. Statins are known to have a 
pleiotropic effect other than its ability to lower serum lipid in the body. Statins inhibit the 
mevalonate pathway by inhibiting the rate-limiting coenzyme HMG-CoA reductase. Statins inhibit 
geranyl-geranyl-pyrophosphate (GGPP), which leads to enhanced expression of eNOS, which can 
be reversed if incubated with GGPP11. Statins reduce GGPP expression, which inhibits activation 




are various other ways how statins to control eNOS expressions like decreasing Caveolin-1 
expression and increasing phosphorylation of eNOS at specific Serine activation sites (Ser-633 
and Ser-1177) through adenosine monophosphate-activated protein kinase (AMPK), Atk and 
protein kinase A (PKA) mediated pathway5. Another way how statin regulates is by upregulating 
the guanosine triphosphate cyclohydrolase I (GTPCH) which is regulated by an increase in 
expression of GCH-1 mRNA. Increase in GTPCH result in increased BH4 availability and leading 
to coupled eNOS, which leads to NO production and endothelium-dependent vasodilation5. 
 
NADPH Oxidase is mainly responsible for ROS generation in Endothelial cells (EC) and Smooth 
muscle cells. NADPH oxidase acts as a catalyst in the conversion of O2 into O2 
– radical by using 
NADPH as a free donor. Statin inhibits the activation of NOX2 complex in EC by lowering the 
synthesis of GGPP expression, reducing its expression leads to inhibition of Rac1 pathway5. It has 
been reported that treating Human umbilical vascular endothelial cells with statin resulted in a 
decrease in s p22phox mRNA and p47pho protein by increasing PPARα activity, which results in 
inhibition of NOX complex12. At the transcriptional level, Transcription factor NF-κB is 
responsible for the expression of a large number of inflammatory genes. When it is inactivated, it 
remains at cytosol bounded to its inhibitor IκBα, which goes proteasomal degradation in the 
presence of ROS. Degradation of IκBα releases NF-κB molecule which goes and binds to the 
nucleus which leads to upregulation of cytokines like IL-6, IL-1b; adhesion molecules like ICAM, 
VCAM; and other inflammatory mediators. Statins prevent the ROS-mediated activation of NF-
κB Pathway by restoring eNOS coupling5. 
 
Although the benefits of Statin outweigh the side effects, still there are certain side effects which 
are worrisome like the elevation of liver enzymes, muscle complaints, moderate risk of diabetes13. 
Thus, there is a need to find an alternative which would be side effect free option for CVD. 
 
1.6 ROLE OF DIETARY POLYPHENOLS IN CVD 
 
Dietary polyphenols are known to have cardioprotective properties. Its anti-inflammatory 
properties, antioxidant, antiangiogenic, and antiproliferative properties are well known. Phenolic 




prevent endothelial dysfunction. The Polyphenols like Quercetin has been shown to cause the Src-
mediated phosphatidylinositol-3-kinase (PI-3-kinase) dependent phosphorylation of Akt which 
leads to activation of eNOS by activation on ser1177 and which leads to the formation of NO in 
the endothelium14. As the chemical structures of polyphenols are so diverse, it affects their ability 
to act on endothelium and characterizing mechanism is challenging. Polyphenols are known to 
decrease the expression of ICAM 1 and ROS. How polyphenols work has a lot to do with their 
chemical structure; studies suggest that total number of the hydroxyl group in structure, the B ring 
3’, 4’ -ortho-dihydroxyl group and the hydroxyl group at the three C position of the ring plays a 
role in inhibition adhesion molecules and thus decrease in ROS15. Polyphenols like 
Pentagalloylglucose (PGG) binds to the proline-rich hydrophobic regions in collagen and elastin 
and form various multiple bonds to nearby proteins and thus result in elastin and collagen stability. 
Polyphenols also decrease ROS formation by targeting NADPH oxidase and downregulating the 
eNOS formation which is going to result in lower expression of regulatory proteins like p53,p21,  
and p16 by activating pathways like Sirtuin1/eNOS (Sirt1/eNOS) and 5’ adenosine 





















AIM & OBJECTIVES 
 
 Aim: The main aim of this study is to assess the role of dietary polyphenols as a cardiovascular 
protectant. 
Objective: The Main Objectives of this project are as follows; 
i) Designing an ex-vivo model system to assess drug-induced vascular injury. 
ii) To check Aortic Tissue Viability. 
iii) To assess the role of PGG, Punicalagin, and Quercetin against drug damage. 
iv) Qualitative (Histology Studies) and Quantitative analysis (Collagen, Elastin and Nitric 



























3.2.1: PERISTALTIC PERFUSION FLOW SYSTEM 
A peristaltic perfusion flow system was developed as an ex vivo aorta testing platform (Figure 2). 
A peristaltic pump (SP100, APT Systems, Omaha, NE) is equipped with a potentiometer (APT 
Systems) to regulate the flow rate. Assuming Hagen–Poiseuille law applies (i.e., incompressible 
and Newtonian fluid in laminar flow through a constant diameter vessel), we set the flow rate, 
which produced a shear rate of 3.0 dyne/cm2 for all our experiments. The viscosity of media was 
calculated using rotatory viscometer (DV E, AMETEK Brookfield, Middleboro, MA), and it was 
~0.72 mPa∙s. Silicone tubing (0.031" ID/0.094" OD) was used for connections throughout the 
system. A reservoir is filled with 10 ml of media (DMEM high glucose with 10% Fetal Bovine 
Serum (FBS) and 1% antibiotic/antimycotic). A silicone sampling port was also used to collect the 
media samples for NO detection every 6 hours for 24 hours. The tubing finally connects to a 50 
ml conical tube (containing DMEM media), which is connected to the rat aorta, as shown in figures 
2 and 3.  
 
Figure 2: Ex-Vivo Rat aortic perfusion system. Peristaltic pumps are connected to media reservoir 






3.2.2:  COLLECTION AND PREPARATION OF RAT AORTAS TO EMBED IN THE 
PERFUSION SYSTEM. 
Twenty-week old, male Sprague Dawley (SD) rat aortas were used in all our experiments. The 
aortas were shipped overnight from Hilltop Lab Animals, Inc. (Scottdale, PA). Upon receiving, 
the aortas were washed 2-3 times in cold, sterile PBS (Hyclone) under the Laminar hood and then 
transferred to a petri dish containing ice-cold DMEM (Hyclone). The silicone tubing (0.031" 
ID/0.094" OD) was inserted on both sides of the aorta (aortic root and abdominal section), which 
was sutured (Prolene, Ethicon, Somerville, NJ) and glued with Histoacryl (TissueSeal, Ann Arbor, 
MI). The branches of the aorta on the arch were also glued to prevent any leakage and was quickly 
placed back in a sterile petri dish containing ice-cold DMEM media (Figure 3). 
 
Figure 3: Preparation of rat’s aorta to embed in a perfusion system. The ends of the aortic root 




glued with histoacryl. The branches at the aortic arch were also glued to prevent any leakage when 
exposed to flow. 
 
3.2.3:  EXPERIMENTAL SETUP 
Once the rat aorta is properly prepared, as shown in Figure 3, and pre-treated with polyphenols as 
described below, is connected to the 50 ml conical tube, as shown in Figure 2. The conical tube 
further connects to the entire peristaltic perfusion system, as explained above. The polyphenol 
pretreatment involves three different molecules: a) Penta galloyl glucose (PGG) b) punicalagin c) 
quercetin,  using the statin lovastatin a the gold standard medication for CVDs and the aorta only 
exposed to media and flow as a control. In total we had 11 groups, either exposed to acetylcholine 
or phenylephrine, to induce vasodilatation or vasoconstriction for 24 hrs, respectively. The specific 
groups are as follows; a) aorta treated with PGG (10 µM) for 6 hours and then exposed to 
acetylcholine (10 µM), b) aorta treated with PGG (10 µM) for 6 hours and then exposed to 
phenylephrine (10 µM) c) aorta treated with punicalagin (10 µM) for 6 hours and then exposed to 
acetylcholine (10 µM), d) aorta treated with punicalagin (10 µM) for 6 hours and then exposed to 
phenylephrine (10 µM), e) aorta treated with quercetin (10 µM) for 6 hours and then exposed to 
acetylcholine (10 µM), f) aorta treated with quercetin (10 µM) for 6 hours and then exposed to 
phenylephrine (10 µM, g) aorta treated with lovastatin (5 uM) for 6 hours and then exposed to 
acetylcholine (10 µM), h) aorta treated with lovastatin (5 µM) for 6 hours and then exposed to 
phenylephrine (10 µM), i) aorta directly exposed to acetylcholine (10 µM), j) aorta directly 
exposed to phenylephrine (10 µM), k) aorta exposed to media without any drugs which act as the 
control. The concentration for each agent was chosen based on the literature [17,18,19,20,21].  
Media samples were collected at an interval of 6 hours to detect the nitric oxide change when 
exposed to drug, and samples were stored at -80°C for NO assay. After 24 hours the tissue was 







3.2.4:  HISTOLOGY STUDY 
Samples were sent to AML Laboratories, Inc. (Jacksonville, FL) for processing and Hematoxylin 
& Eosin (H&E) staining for each sample. To check tissue viability after the 24 hour perfusion of 
the control group, we used the IHC kit (Abcam# 64260, Cambridge, UK) following the 
manufacturer’s guidelines. The tissue section slides were deparaffinized and rehydrated. Hydrogen 
peroxide drops were added, to completely cover the slide for blocking. The slides were incubated 
for ten minutes and then washed twice with wash buffer. To check for Apoptosis Caspase-3 
antibody (Abcam) drops were added as per manufacturers recommended concentration such that 
it covered the section completely and was left for incubation overnight in 4°C. The next morning 
slides were washed three to four times in buffer. Biotinylated goat anti-rabbit was applied and 
incubated for ten minutes at room temperature, followed by three to four washes. The counterstain 
was applied on the slides, and it was observed under the microscope. 
 
3.2.5:  SIRCOL COLLAGEN ASSAY 
The Sircol Collagen Assay (Biocolor Ltd, Carrickfergus, UK) is a dye-binding method for the 
analysis of acid and pepsin-soluble collagens. This assay is suitable for monitoring collagen 
produced in situ or during in vitro cell culture and in vitro extracellular matrix, (ECM), formation. 
The tissue samples were weighed; the samples were then homogenized in 1 ml of 1× PBS. For 
more precise results, the homogenate was spun for 10 minutes at 2000 rpm. Tissue sample 
homogenates (100µl) were pipetted into labeled Eppendorf tubes. One milliliter of Sircol dye was 
added to each sample. Tubes were left on a mechanical shaker for 30 minutes at room temperature 
to ensure proper mixing. The sample tubes were spun at 5000g for 5 minutes. The unbound dye 
solution was drained carefully by turning the tube upside down on a tissue; remove any remaining 
droplets from the top half of the tube with a tissue.  To each tube 1ml of alkali (NaOH) reagent 
was added.  Tubes were vortexed thoroughly to release any bound dye into the solution for 10 
minutes. Transfer 100 µl of the unbound dye to a 96 well plate and samples were read with a 540 






3.2.6: FASTIN ELASTIN ASSAY 
The Fastin Elastin Assay (Accurate Chemicals, Westbury, NY) measures the insoluble cross-
linked elastin, by extracting it from the tissue sample. The tissue samples were weighed and were 
transferred in 750 μl of 0.25 M oxalic acid in an Eppendorf tube. The tubes were then transferred 
to a water bath which was to 100°C and heated for 2 hours. Tubes were further removed from the 
water bath and left at room temperature for a few minutes to let them cool. Then tubes were 
centrifuged at 10,000 rpm for 10 minutes. The supernatant was pipetted out, and the extract was 
retained in labeled containers for analysis. The extraction process was repeated three times until 
the entire residue gets dissolved. 500 μl of the extract was taken in a tube, and another 500 μl of 
precipitating reagent was added. The solution was centrifuged at 10,000 rpm for 10 minutes and 
the supernatant was discarded. For the dye-binding step, 500 μl of dye was added to the pellet, 
followed by a vortex and centrifuged at 10,000 rpm for 10 minutes. The supernatant was discarded. 
During the dye dissociation step, 250 μl of dissociation reagent was added. The samples were then 
transferred to 96 well-plates and read at 513 nm. All the reading was normalized to the wet weight 
of the samples. 
 
3.2.7: NITRIC OXIDE ASSAY 
For NO estimation, Nitrate/Nitrite fluorometric assay kit from Cayman chemicals was used (Cat 
# 780051). After thawing, the samples were concentrated, and proteins were removed using 10,000 
MWCO corning concentrator (Cat # CLS43147, Ann Arbor, MI). Ten μl of the sample was added 
to 70 μl of assay buffer (provided in the kit). Then 10 μl of enzyme cofactor (provided in the kit) 
was added to each well (96 well plate), followed by addition of 10 μl of nitrate reductase mixture 
(provided in the kit) to each well. The plates were incubated for a 2 hours. After incubation the 
DAN reagent (provided in the kit) was added to each well, followed by a 10 minute incubation. 
Then 20 μl of NaOH (provided in the kit) was added to each well to stop the reaction. Microwell 
plates were read at excitation and emission wavelength of 375 and 417 nm, respectively. Each 








RESULTS & DISCUSSION 
4.1: AORTIC TISSUE VIABILITY UNDER PERFUSION 
The first step was to study the aorta tissue viability, to assess the effect of being exposed to 
continuous flow for 24 hours. H&E staining was performed to assess the structural integrity of the 
aorta (Figure 4a). Staining shows intact membranes, with no signs of structural damage observed. 
Caspase 3 antibody staining shows a lack of red dots related to apoptotic cells, as shown in Figure 
4b. This result confirms that our inflow perfusion system does not harm the integrity of the vessel 
wall, providing a good model for the proposed experiments. 
         
 
Figure 4: Aortic Tissue Viability: After aorta were perfused for 24 hours. a) H&E staining shows 







4.2: QUALITATIVE ANALYSIS (HISTOLOGY STUDY) 
The Qualitative Analysis was based on H&E tissue staining to assess the protective properties of 
polyphenols. The results show polyphenols help maintain the integrity of the membrane when 
compared to the controls directly exposed to drug agents. The structural similarity between vessels 
exposed to polyphenols and statin are equivalent (Figure 5). It thus verifies the cardio-protectant 








      Figure 5: Histology analysis of all the samples A) aorta treated with PGG (10 µM) for 6 hours 
and then exposed to acetylcholine (10 µM), B) aorta treated with PGG (10 µM) for 6 hours and 
then exposed to phenylephrine (10 µM) C aorta treated with punicalagin (10 µM) for 6 hours and 
then exposed to acetylcholine (10 µM), D) aorta treated with punicalagin (10 µM) for 6 hours and 
then exposed to phenylephrine (10 µM), E) aorta treated with quercetin (10 µM) for 6 hours and 
then exposed to acetylcholine (10 µM), F) aorta treated with quercetin (10 µM) for 6 hours and 
then exposed to phenylephrine (10 µM, G) aorta treated with lovastatin (5 uM) for 6 hours and 
then exposed to acetylcholine (10 µM), H) aorta treated with lovastatin (5 µM) for 6 hours and 
then exposed to phenylephrine (10 µM), I) aorta directly exposed to acetylcholine (10 µM), J) 
aorta directly exposed to phenylephrine (10 µM), K) aorta exposed to media without any drugs 










4.3 QUANTITATIVE ANALYSIS 
4.3.1 ESTIMATION OF NITRIC OXIDE RELEASE (NO ASSAY) 
 
 
Figure 6(a): Comparative estimation of NO release from aortas pretreated with PGG before being 
exposed to statin, acetylcholine, and phenylephrine. 
 
Figure 6(b): Comparative estimation of NO release from aortas pretreated with punicalagin 








































Figure 6(c): Comparative estimation of NO release from aortas pretreated with quercetin before 
being exposed to statin, acetylcholine, phenylephrine, and control. 
 
4.3.2: ESTIMATION OF COLLAGEN ASSAY (SIRCOL COLLAGEN ASSAY) 
 
 
Figure 7: Collagen content from rat aorta pretreated with polyphenols (i.e., PGG, punicalagin, 
and quercetin) before being exposed to drugs versus directly exposed to drugs. Control group 































4.3.3: ESTIMATION OF ELASTIN ASSAY (FASTIN ELASTIN ASSAY) 
 
 
Figure 8: Elastin Content readings from rat aorta when pretreated with polyphenols (i.e., PGG, 
punicalagin, and quercetin) before being exposed to drugs versus directly exposed to drugs. 



























Dietary polyphenols have been part of people’s diet for a long time. This project was an attempt 
to understand its cardio-protectant properties. We show how polyphenols can be used as a cardio-
protectant agent against drug-induced vascular injury without limiting side effects. H&E staining 
of the aortic tissues show intact membranes, and there no signs of damage. Caspase 3 antibody 
staining shows no red dots related to apoptotic cells. All the polyphenols show a higher collagen 
content when compared to the control. PGG and punicalagin show less nitrate content when 
compared to the statin in the NO Assay. Another interesting finding was the amount of elastin 
decreased when mechanical forces are absent for 24 hours. This might be due to activities of shear 
stress-sensitive elastases, cathepsin. Whereas, it was compeletely opposite, in the case of collagen 
that might be due to the collagenase activity of MMP. 
We believe polyphenols have great potential as a cardio protectant. However, due to certain 
constraints, we were not able to add replicates to our study. The future direction for this project is 
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